PTD-DBM represents one component of what may eventually become standardized multi-target protocols incorporating Wnt activation, DHT reduction, growth factor supplementation, anti-inflammatory agents, and regenerative peptides
doi: 10.1016/j.ccc.2012.07.006 [PubMed] 25133498 Gosselin S, Juurlink DN, Kielstein JT, Ghannoum M, Lavergne V, Nolin TD, Hoffman RS
Schedule: Subcutaneous injections for 812 weeks (extend to 16 weeks if desired)
In der subkutanen Anwendungsforschung wurden gelegentlich lokale Reaktionen an der Injektionsstelle beobachtet, darunter leichte Roetung und voruebergehende Schwellung, die typischerweise innerhalb von 24 Stunden abklangen
Supports the liver in the removal of waste products and toxins Helps the immune system function better in chronic complaints Protects cells from damage caused by disease, medication or old age Relevant for liver stress, chronic illness and recovery after anesthesia Liposomal form reaches the cells where regular glutathione does not When do you see results
All IVs use specialty compounded materials with the cleanest nutrients for maximum uptake and benefit